![](/img/cover-not-exists.png)
Efficacy of Bortezomib as an Adjunctive Therapy for Refractory Chronic Active Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience
Larpparisuth, Nuttasith, Skulratanasak, Peenida, Premasathian, Nalinee, Vongwiwatana, AttapongLanguage:
english
Journal:
Transplantation Proceedings
DOI:
10.1016/j.transproceed.2019.07.022
Date:
November, 2019
File:
PDF, 440 KB
english, 2019